Clinical trials
Type 2 Diabetes Treated With Insulin clinical trials
Below are recruiting type 2 diabetes treated with insulin clinical trials, each written for real people, not researchers. We’re tracking 119 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05795439Recruiting
Plant-based nutrition program for adults with type 2 diabetes
This study tests whether a structured plant-based diet plan, weekly online classes, and keeping exercise routine steady can improve health in adults with type 2 diabetes. You may qualify if you’re able and willing to follow the program for the first 16 weeks.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06706284RecruitingPhase 4
GLP-1 agonist for diabetes after spinal cord injury
This trial tests whether a GLP-1 agonist (a type of diabetes medicine that also helps with weight loss) is safe and effective for people with spinal cord injury and type 2 diabetes who are not on other glucose-lowering drugs.
San Antonio, TexasAges 18–70 - NCT07431359Recruiting
Mediterranean diet study for type 2 diabetes patients
This trial looks at what people with type 2 diabetes know about diet and how often they eat a Mediterranean diet. It aims to understand if this way of eating can help with diabetes management.
Peschiera del Garda, VeronaAges 18–80 - NCT05390892RecruitingPhase 4
Preventing kidney and heart damage in type 2 diabetes
This study tests whether diabetes medicines can help prevent worsening heart and kidney problems in people with type 2 diabetes. You’ll be assigned by chance to one of these medicine types, and your other care will be adjusted for safety.
Huntsville, AlabamaAges 40–80 - NCT07415720Recruiting
Artichoke and Mediterranean diet to prevent type 2 diabetes
This study tests whether a special extract from artichoke by-products, combined with a Mediterranean diet, can help prevent type 2 diabetes in people who are at risk. It aims to improve how your body handles sugar and insulin.
Pamplona, NavarreAges 18–75 - NCT07414277Recruiting
CGM for insulin-treated type 2 diabetes after hospital discharge
This study tests whether using a continuous glucose monitor (CGM) can help people with type 2 diabetes who need insulin after leaving the hospital. It aims to improve blood sugar control during this transition period.
ShanghaiAges 18–80 - NCT07336329Recruiting
Continuous glucose monitor use in type 2 diabetes
This study compares wearing a continuous glucose monitor (CGM) all the time versus only now and then for people with type 2 diabetes who do not use insulin. It aims to see which way helps manage blood sugar better.
Seoul, South KoreaAges 19–80 - NCT07307235RecruitingPhase 4
Comparing a new diabetes combination to standard care for type 2 diabetes
This trial tests if a once-daily injectable combination (iGlarLixi) helps control blood sugar better than usual care for people with type 2 diabetes who are already taking diabetes pills. It aims to find a more effective treatment option.
Hefei, AnhuiAges 18 years+ - NCT07282613RecruitingPhase 3
CagriSema for blood sugar and weight in children with type 2 diabetes
This study tests a new medicine called CagriSema to see if it can lower blood sugar and help with weight loss in children and teens with type 2 diabetes. It compares the medicine to a placebo (a look-alike with no active drug) over several months.
New Haven, ConnecticutAges 10–18 - NCT07262788Recruiting
Lifestyle program for recently diagnosed type 2 diabetes
This study tests whether a carefully guided lifestyle program (diet and exercise) can help people who were recently diagnosed with type 2 diabetes achieve remission—meaning their blood sugar stays normal without medication. You may be a good fit if you are overweight, not on insulin, and have had diabetes for less than 6 years.
Herlev, DenmarkAges 18–75 - NCT07197788Enrolling by invitation
Continued access to the Endogenex device study for type 2 diabetes
This trial offers continued access to the Endogenex system for people who were in the sham (placebo) group of the ReCET study and have completed their 12-month visit. It tests a device that treats the duodenum to improve blood sugar control.
Miami, FloridaAges 22 years+ - NCT07193459RecruitingPhase 3
Study of an oral tablet for type 2 diabetes
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
Beijing, Beijing MunicipalityAges 18–75 - NCT07568678RecruitingPhase 1
Testing HMS1005 in adults with type 2 diabetes
This study tests a new medicine called HMS1005 in people with type 2 diabetes. Researchers want to see how safe it is and how the body responds to different doses. You may qualify if you have type 2 diabetes that is either untreated or controlled with common diabetes medications.
Miami, FloridaAges 18–65 - NCT07165223RecruitingPhase 3
Testing a new insulin for type 2 diabetes
This trial tests a new weekly insulin called GZR4 for people with type 2 diabetes who already use basal insulin. It aims to see how well it controls blood sugar and if it is safe.
Linyi, ShandongAges 18 years+ - NCT02861781Recruiting
Collecting body tissue samples during bariatric surgery
This study collects small tissue samples during planned weight-loss surgery to better understand metabolism and how insulin works in people with and without type 2 diabetes. You may help researchers by allowing their team to take these samples while you are already having surgery.
MontpellierAges 18–65 - NCT07118475Enrolling by invitationEarly Phase 1
Islet transplant for type 2 diabetes
This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.
ShanghaiAges 18–75 - NCT07121504Recruiting
Hybrid closed-loop insulin for blood sugar control during surgery
This trial tests a smart insulin pump system (hybrid closed-loop) to control blood sugar in people with type 2 diabetes who need surgery and will receive nutrition through a vein. It aims to prevent high and low blood sugar during and after surgery.
Changsha, HunanAges 18 years+ - NCT07097818Recruiting
GLITTER Study: Better Blood Sugar Control in Type 1 Diabetes
This study tests a program to help people with type 1 diabetes improve their blood sugar control using continuous glucose monitors, insulin pumps, and education sessions. It includes remote monitoring and camp activities for some participants.
Beijing, Beijing MunicipalityAges 6 years+ - NCT07082114RecruitingPhase 3
Testing a new tablet for type 2 diabetes
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
Yueyang, HunanAges 18–75 - NCT07083336Recruiting
Diet study for type 2 diabetes with fatty liver disease
This trial tests a specific medical nutrition therapy diet to see if it can reduce liver fat and improve blood sugar control in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help you manage both conditions with a dietary approach.
Yichang, HubeiAges 18 years+ - NCT07060456RecruitingPhase 3
New drug for type 2 diabetes with insulin
This trial tests a new medicine called HRS9531 for people with type 2 diabetes who already use basal insulin. It aims to see if adding this drug helps control blood sugar better.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07061301Recruiting
Leaving the hospital with insulin: a transition study
This study helps people with type 2 diabetes who just started using insulin in the hospital get ready to go home. It tests whether extra support and tools like a smart insulin cap and a continuous glucose monitor make the switch safer and easier.
Valencia, ValenciaAges 18–70 - NCT07038473Recruiting
Early detection of type 1 diabetes in relatives
This study screens brothers, sisters, and children of people with type 1 diabetes to find early signs of the disease before symptoms appear. The goal is to catch it early and offer monitoring or future prevention options.
Kuwait City, Al Asimah / Capital GovernorateAges 1.5 years–18 years - NCT07007676Recruiting
Continuous glucose monitor for older adults with type 2 diabetes
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
Shenzhen, GuandongAges 60 years+
Hear when a new Type 2 Diabetes Treated With Insulin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes treated with insulin?
- Yes. Clin2 currently lists 119 recruiting type 2 diabetes treated with insulin studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes treated with insulin trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes treated with insulin trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.